======= TOE1 ======= == Gene Information == * **Official Symbol**: TOE1 * **Official Name**: target of EGR1, exonuclease * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=114034|114034]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96GM8|Q96GM8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TOE1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TOE1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/613931|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Inhibits cell growth rate and cell cycle. Induces CDKN1A expression as well as TGF-beta expression. Mediates the inhibitory growth effect of EGR1. Involved in the maturation of snRNAs and snRNA 3'-tail processing (PubMed:28092684). {ECO:0000269|PubMed:12562764, ECO:0000269|PubMed:28092684}. |CAF1| |zf-CCCH| |snRNA binding| |poly(A)-specific ribonuclease activity| |snRNA 3-end processing| |3-5-exoribonuclease activity| |snRNA processing| |RNA phosphodiester bond hydrolysis, exonucleolytic| |snRNA metabolic process| |ncRNA 3-end processing| |Cajal body| |RNA 3-end processing| |RNA phosphodiester bond hydrolysis| |nuclear body| |nucleic acid phosphodiester bond hydrolysis| |ncRNA processing| |nuclear speck| |ncRNA metabolic process| |nucleolus| |RNA processing| |RNA metabolic process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp453|B02 10μM R08 exp453]]|-1.83| |[[:results:exp469|CFI-400945 25μM R08 exp469]]|-1.74| |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|-1.72| |[[:results:exp362|GSK-J4 1μM R07 exp362]]|-1.7| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|1.7| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|1.73| |[[:results:exp314|Dimethyloxaloylglycine 11μM R07 exp314]]|1.75| |[[:results:exp85|UM0129480 7μM R02 exp85]]|1.89| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|1.9| |[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|2.07| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|2.47| ^Gene^Correlation^ |[[:human genes:h:hgc6.3|HGC6.3]]|0.445| Global Fraction of Cell Lines Where Essential: 166/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|1/1| |bile duct|6/28| |blood|7/28| |bone|6/26| |breast|3/33| |central nervous system|15/56| |cervix|0/4| |colorectal|5/17| |esophagus|4/13| |fibroblast|0/1| |gastric|2/16| |kidney|3/21| |liver|5/20| |lung|17/75| |lymphocyte|1/16| |ovary|11/26| |pancreas|7/24| |peripheral nervous system|2/16| |plasma cell|0/15| |prostate|0/1| |skin|1/24| |soft tissue|4/9| |thyroid|0/2| |upper aerodigestive|2/22| |urinary tract|11/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1606 * **Expression level (log2 read counts)**: 5.17 {{:chemogenomics:nalm6 dist.png?nolink |}}